Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study

Trial Profile

Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2016

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 May 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Jul 2016.
    • 01 Dec 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Dec 2015 as per ClinicalTrials.gov record.
    • 27 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top